Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 11 (1), 71
- https://doi.org/10.1186/1477-7525-11-71
Abstract
Purpose: The three most widely used utility measures are the Health Utilities Index Mark 2 and 3 (HUI2 and HUI3), the EuroQol-5D (EQ-5D) and the Short-Form-6D (SF-6D). In line with guidelines for economic evaluation from agencies such as the National Institute for Health and Clinical Excellence (NICE) and the Canadian Agency for Drugs and Technologies in Health (CADTH), these measures are currently being used to evaluate the cost-effectiveness of different interventions in MS. However, the challenge of using such measures in people with a specific health condition, such as MS, is that they may not capture all of the domains that are impacted upon by the condition. If important domains are missing from the generic measures, the value derived will be higher than the real impact creating invalid comparisons across interventions and populations. Therefore, the objective of this study is to estimate the extent to which generic utility measures capture important domains that are affected by MS. Methods: The available study population consisted of men and women who had been registered after 1994 in three participating MS clinics in Greater Montreal, Quebec, Canada. Subjects were first interviewed on an individualized measure of quality of life (QOL) called the Patient Generated Index (PGI). The domains identified with the PGI were then classified and grouped together using the World Health Organization's International Classification of Functioning, Disability and Health (ICF), and mapped onto the HUI2, HUI3, EQ-5D and SF-6D. Results: A total of 185 persons with MS were interviewed on the PGI. The sample was relatively young (mean age 43) and predominantly female. Both men and women had mild disability with a median Expanded Disability Status Scale (EDSS) score of 2. The top 10 domains that patients identified to be the most affected by their MS were, work (62%), fatigue (48%), sports (39%), social life (28%), relationships (23%), walking/mobility (22%), cognition (21%), balance (14%), housework (12%) and mood (11%). The SF-6D included the most number of domains (6 domains) important to people with MS, followed by the EQ-5D (4 domains) and the HUI2 (4 domains) and then the HUI3 (3 domains). The mean and standard deviation (SD) for the PGI, EQ-5D and the SF-6D were 0.50 (SD 0.25), 0.69 (0.18) and 0.69 (0.13), respectively. The magnitude of difference between the PGI and the generic utility measures was large and statistically significant. Conclusion: Although the generic utility measures included certain items that were important to people with MS, there were several that were missing. An important consequence of this mismatch was that values of QOL derived from the PGI were importantly and significantly lower than those estimated using any of the generic utility measures. This could have a substantial impact in evaluating the effect of interventions for people with MS.Keywords
This publication has 63 references indexed in Scilit:
- Web-Based Self-Management for Patients with Multiple Sclerosis: A Practical, Randomized TrialTelemedicine and e-Health, 2011
- The Effect of Telephone-Administered Cognitive–Behavioral Therapy on Quality of Life among Patients with Multiple SclerosisAnnals of Behavioral Medicine, 2010
- MS quality of life, depression, and fatigue improve after mindfulness trainingNeurology, 2010
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosisMultiple Sclerosis Journal, 2010
- Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analysesHealth and Quality of Life Outcomes, 2008
- Health‐related quality of life in multiple sclerosis: effects of natalizumabAnnals of Neurology, 2007
- Multi-Attribute Health Status Classification SystemsPharmacoEconomics, 1995
- Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation.Thorax, 1992
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987
- Standards for validating health measures: Definition and contentJournal of Chronic Diseases, 1987